L1CAM and breast cancer: Stromal endothelial cells showed enrichment in development- and immune-related pathways (e.g., L1CAM interactions and antigen processing & presentation), contributing to aggressive BC progression and immune evasion with implications for both chemo and immunotherapy [68][69][70][71][72][73][74].